Our experiments demonstrated that CP, and AP, in their naïve forms, exhibit significant in vitro cytotoxicity against Breast cancer cells in a dose- and time-dependent manner, and for the first time in this study, we showed that CP, and AP are able to interact with double-helix DNA. This evidence concerns the gene CP and breast cancer.